"While GLP-1 medications affect gastrointestinal tract motility, their quantified impact may not be as significant as previously assumed, said corresponding author, Dr Walter Chan, director of the Center of Gastrointestinal Motility and a physician in the Brigham's Division of Gastroenterology, Hepatology and Endoscopy
doi: 10.1002/dmrr.2810 108 BarringtonPChienJYShowalterHDHSchneckKCuiSTibaldiFet al
In contrast, in pediatric cases with severe, life-threatening early-onset obesity, the primary achievement may be halting relentless disease progression and weight gain, a milestone in itself, alongside improvements in insulin sensitivity, liver enzymes, and notably, behavioral domains such as concentration and emotional stability
As interest in GLP-1 therapy continues to grow, many conversations focus less on the medications themselves and more on everyday realities such as GLP-1 cost, GLP-1 side effects, and GLP-1 accessibility
Insurance-reimbursed care becomes more important when treatment costs rise or long-term use is expected
This benefit makes it a highly effective option for managing weight
